Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Management of refractory breathlessness in patients with advanced cancer.

Authors
  • Simon, Steffen T
  • Bausewein, Claudia
Type
Published Article
Journal
Wiener medizinische Wochenschrift (1946)
Publication Date
Dec 01, 2009
Volume
159
Issue
23-24
Pages
591–598
Identifiers
DOI: 10.1007/s10354-009-0728-y
PMID: 20151348
Source
Medline
License
Unknown

Abstract

Breathlessness is a common and distressing symptom in advanced cancer. Management comprises non-pharmacological and pharmacological interventions, which are best combined. There is some evidence mainly derived from COPD studies for walking aids, neuro-muscular electrical stimulation, fan and breathlessness services. Opioids are the drugs of choice for pharmacological management of breathlessness. There is currently not enough evidence to support the routine use of benzodiazepines, other anxiolytics, antidepressants, phenothiazines, inhaled furosemide and oxygen.

Report this publication

Statistics

Seen <100 times